CASCADE 2002: PROTECT Study, "PRObiotics to TrEat Anal preCancer Trial | MicrobiomeTrials← Back to trialsNCT06949800
CASCADE 2002: PROTECT Study, "PRObiotics to TrEat Anal preCancer Trial
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-09-04Est. Completion: 2027-05-31
Enrollment target: 90 participants Locations- University of California, San Francisco, San Francisco, California, United States
- University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico
Other microbiome trials you might be interested in
High-grade Squamous Intraepithelial Lesions (HSIL)
This study is intented to evaluate the safety, and tolerability and preliminary efficacy of Instantaneous CRISPR/Cas9 Ge…
Shanghai, ChinaCompleted Aug 21, 2026
NeoplasmsHPV-Related Anal Squamous Cell Carcinoma
The goal of the proposed research is to 1) examine the performance of emerging screening methods for anal high-grade squ…
Miami, United StatesEst. completion Sep 30, 2027